Statin linked to improved outcomes in COVID-19 patients, vitamin C shows no benefits
Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.
Clinical trials show vitamin C was not beneficial in critically ill COVID-19 patients, but the statin drug simvastatin had a 96% likelihood of improving outcomes.